"El Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) constituye un espacio de investigación multidisciplinar en biomedicina pionero en España, ya que integra la investigación básica y aplicada con la finalidad de traducir los resultados de los trabajos científicos en mejoras directas en la salud y en la calidad de vida de los ciudadanos."

During the past decade, CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)" #1 collaborator was "Iniciativa Andaluza en Terapias Avanzadas" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)" are "Critical Limb Ischemia (CLI)" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)" in a lesser frequency.

Most popular intervention types in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Autologous adipose derived mesenchymal stem cells" (1 trials) and "Stem cell infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine), 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".